Catching cancer early is an incredible challenge, but a new way to detect it in the blood may totally revolutionize cancer treatment in just a few years.
Illumina, the $25 billion maker of gene sequencing technology, has created a new company to invent a blood test to detect all cancers in their early stages, something that would be a tremendous help to those trying to detect the illness before it is too difficult to treat effectively.
This isn't the first attempt of this nature, and previous efforts by other companies have been criticized for having too little research behind them or focusing too much on detection rather than treatment.